These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 14648231
1. The C(-260)>T gene polymorphism in the promoter of the CD14 monocyte receptor gene is not associated with acute myocardial infarction. Longobardo MT, Cefalù AB, Pezzino F, Noto D, Emmanuele G, Barbagallo CM, Fiore B, Monastero R, Castello A, Molini V, Notarbartolo A, Travali S, Averna MR. Clin Exp Med; 2003 Nov; 3(3):161-5. PubMed ID: 14648231 [Abstract] [Full Text] [Related]
2. CD14 C(-260)T promoter polymorphism and prevalence of acute coronary syndromes. Arroyo-Espliguero R, El-Sharnouby K, Vázquez-Rey E, Kalidas K, Jeffery S, Kaski JC. Int J Cardiol; 2005 Feb 15; 98(2):307-12. PubMed ID: 15686783 [Abstract] [Full Text] [Related]
3. C(-260)T polymorphism in the promoter of CD 14 gene is not associated with myocardial infarction in the Tunisian population. Sediri Y, Hammami S, Kallel A, Mourali MS, Feki M, Elasmi M, Haj-Taieb S, Omar S, Sanhaji H, Mechmeche R, Jemaa R, Kaabachi N. Exp Mol Pathol; 2011 Jun 15; 90(3):276-9. PubMed ID: 21333644 [Abstract] [Full Text] [Related]
4. Influence of the CD14 C260T promoter polymorphism on C-reactive protein levels in patients with coronary artery disease. Bernardo E, Angiolillo DJ, Ramírez C, Cavallari U, Trabetti E, Sabaté M, Hernández R, Moreno R, Escaned J, Alfonso F, Bañuelos C, Costa MA, Bass TA, Pignatti PF, Macaya C, Fernandez-Ortiz A. Am J Cardiol; 2006 Nov 01; 98(9):1182-4. PubMed ID: 17056323 [Abstract] [Full Text] [Related]
5. CD14 gene polymorphism 159C/T in a group of patients with coronary artery disease from a population with high morbidity of cardiovascular diseases. Rechciński T, Grebowska A, Kurpesa M, Peruga Z, Dziuba M, Krzemińska-Pakuła M, Rudnicka W, Chmiela M. Kardiol Pol; 2007 Mar 01; 65(3):237-44; discussion 245. PubMed ID: 17436151 [Abstract] [Full Text] [Related]
6. Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease. Järveläinen HA, Orpana A, Perola M, Savolainen VT, Karhunen PJ, Lindros KO. Hepatology; 2001 May 01; 33(5):1148-53. PubMed ID: 11343243 [Abstract] [Full Text] [Related]
7. The CD14 -159C-to-T promoter polymorphism in periodontal disease. Folwaczny M, Glas J, Török HP, Fricke K, Folwaczny C. J Clin Periodontol; 2004 Nov 01; 31(11):991-5. PubMed ID: 15491315 [Abstract] [Full Text] [Related]
8. Promoter polymorphism of the CD14 endotoxin receptor gene is associated with biliary atresia and idiopathic neonatal cholestasis. Shih HH, Lin TM, Chuang JH, Eng HL, Juo SH, Huang FC, Chen CL, Chen HL. Pediatrics; 2005 Aug 01; 116(2):437-41. PubMed ID: 16061600 [Abstract] [Full Text] [Related]
9. Lack of association between the -260 C-->T promoter polymorphism of the endotoxin receptor CD14 gene and the CD14 density of unstimulated human monocytes and soluble CD14 plasma levels. Heesen M, Blömeke B, Schlüter B, Heussen N, Rossaint R, Kunz D. Intensive Care Med; 2001 Nov 01; 27(11):1770-5. PubMed ID: 11810121 [Abstract] [Full Text] [Related]
10. The -260 C-->T promoter polymorphism of the lipopolysaccharide receptor CD14 and severe sepsis in trauma patients. Heesen M, Bloemeke B, Schade U, Obertacke U, Majetschak M. Intensive Care Med; 2002 Aug 01; 28(8):1161-3. PubMed ID: 12185442 [Abstract] [Full Text] [Related]
11. Lipopolysaccharide receptor CD14 polymorphism and risk of stroke in a South-German population. Lichy C, Meiser H, Grond-Ginsbach C, Buggle F, Dörfer C, Grau A. J Neurol; 2002 Jul 01; 249(7):821-3. PubMed ID: 12140663 [Abstract] [Full Text] [Related]
12. Polymorphism in the promoter region of the CD14 gene and susceptibility to Brucellosis. Haidari M, Hajilooi M, Rezazadeh M, Rafiei A, Alavi SA, Keramat F. Immunol Invest; 2006 Jul 01; 35(2):239-45. PubMed ID: 16698680 [Abstract] [Full Text] [Related]
13. CD14 expression on monocytes and soluble CD14 plasma levels in correlation to the promotor polymorphism of the endotoxin receptor CD14 gene in patients with inactive Crohn's disease. Griga T, Klein W, Epplen JT, Hebler U, Stachon A, May B. Hepatogastroenterology; 2005 Jul 01; 52(63):808-11. PubMed ID: 15966209 [Abstract] [Full Text] [Related]
14. CD14 C(-159)T polymorphism is a risk factor for development of pulmonary tuberculosis. Rosas-Taraco AG, Revol A, Salinas-Carmona MC, Rendon A, Caballero-Olin G, Arce-Mendoza AY. J Infect Dis; 2007 Dec 01; 196(11):1698-706. PubMed ID: 18008256 [Abstract] [Full Text] [Related]
15. A CD14 monocyte receptor polymorphism and genetic susceptibility to Parkinson's disease for females. Lin JJ, Chen CH, Yueh KC, Chang CY, Lin SZ. Parkinsonism Relat Disord; 2006 Jan 01; 12(1):9-13. PubMed ID: 16337421 [Abstract] [Full Text] [Related]
16. Association between the promoter polymorphism T/C at position -159 of the CD14 gene and anti-inflammatory therapy in patients with inflammatory bowel disease. Griga T, Wilkens C, Schmiegel W, Folwaczny C, Hagedorn M, Duerig N, Epplen J, Klein W. Eur J Med Res; 2005 May 20; 10(5):183-6. PubMed ID: 15946916 [Abstract] [Full Text] [Related]
17. The common functional C(-159)T polymorphism within the promoter region of the lipopolysaccharide receptor CD14 is not associated with sepsis development or mortality. Hubacek JA, Stüber F, Fröhlich D, Book M, Wetegrove S, Rothe G, Schmitz G. Genes Immun; 2000 Aug 20; 1(6):405-7. PubMed ID: 11196689 [Abstract] [Full Text] [Related]
18. Common promoter polymorphism in monocyte differentiation antigen CD14 is associated with serum triglyceride levels and body mass index in non-diabetic individuals. Shin HD, Park KS, Park BL, Cheong HS, Cho YM, Lee HK, Lee JY, Lee JK, Kim HT, Han BG, Kim JW, Koh I, Kim YJ, Oh B, Kimm K, Park C. Diabet Med; 2006 Jan 20; 23(1):72-6. PubMed ID: 16409569 [Abstract] [Full Text] [Related]
19. Is the CD14 receptor gene a marker for smoking dependence? Hubacek J, Pitha J, Skodova Z, Poledne R. Med Sci Monit; 2002 May 20; 8(5):BR172-4. PubMed ID: 12011764 [Abstract] [Full Text] [Related]
20. A polymorphism in the promoter of the CD14 gene (CD14/-159) is associated with the development of coronary artery lesions in patients with Kawasaki disease. Nishimura S, Zaitsu M, Hara M, Yokota G, Watanabe M, Ueda Y, Imayoshi M, Ishii E, Tasaki H, Hamasaki Y. J Pediatr; 2003 Sep 20; 143(3):357-62. PubMed ID: 14517520 [Abstract] [Full Text] [Related] Page: [Next] [New Search]